Link Cell Therapies ("Link"), an oncology cell therapy company, today announced its official launch from stealth with a $60 ...
Cell therapy company Link Cell Therapies is launching with $60 million and a mission to develop potent CAR-T therapies that ...
Our roundup of financings in the biotech arena this week is led by a $125 million Series A for Ambros Therapeutics, a startup ...
When delivering radiation therapy to a tumor, clinicians want to be as precise as possible, using imaging, such as CT scans, to ensure the radiation targets the right area. However, when a tumor is ...
Artificial intelligence-supported cell imaging could help laboratories to set defensible quality thresholds for living ...
Morning Overview on MSN
Scientists uncover how tiny nanopores learn like a brain
Scientists are beginning to show that learning is not exclusive to neurons and synapses. At the scale of billionths of a ...
Morning Overview on MSN
A new quantum chemistry approach is cracking tough material mysteries
Quantum chemistry is quietly entering a new phase, one where some of the hardest problems in materials science are finally ...
The second in a series of articles recapping sessions from the Data Center Frontier Trends Summit 2025 (Aug. 26-28) in Reston, Va. Northern Virginia's AI-driven demand has rapidly outpaced existing ...
For the first time, researchers have been able to show how a cell closes the door to free radicals—small oxygen molecules ...
Researchers at Karolinska Institutet and KTH have developed a computational method that can reveal how cells change and ...
In this GEN webinar, DNA synthesis experts Michael Junkin, PhD, and Brittany Enzmann, PhD, will provide an exclusive first look at Elegen’s GEN II Cell-Free DNA production platform that combines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback